PENNINGTON BIOMEDICAL RESEARCH FOUNDATION
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2024 (Year End)
$29,530,991
Investments
92%
Receivables (Non-Related)
6%
Cash & Equivalents
2%
Other Assets
<1%
Prepaid Expenses
<1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$7,740,985
Other Liabilities
88%
Deferred Revenue
9%
Payables & Accruals
3%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$449,266
$492,386
+10%
Receivables (Non-Related)
$1,206,670
$1,848,112
+53%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$39,138
$43,546
+11%
Investments
$24,470,777
$27,059,039
+11%
Property, Plant, & Equipment (net)
$0
$9,058
-
Other Assets
$18,224
$78,850
+333%
Total Assets
$26,184,075
$29,530,991
+13%
Liabilities
2023
2024
Change
Payables & Accruals
$274,779
$202,793
-26%
Grants Payable
-
-
-
Deferred Revenue
$748,592
$727,815
-3%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$6,701,726
$6,810,377
+2%
Total Liabilities
$7,725,097
$7,740,985
+0%
Net assets
2023
2024
Change
Restricted Net Assets
$16,371,417
$19,545,163
+19%
Unrestricted Net Assets
$2,087,561
$2,244,843
+8%
Net assets
2023
2024
Change
Net assets
+$18,458,978
+$21,790,006
+18%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)